Member Info for Monkshood

@Livepair- don't forget that there was a 20% equity dilution plus the additional 350M mezzanine debt since it was 460.
Without covid, and with the expansion in Morocco it would probably have been nearer to 500. So a reasonable target would be nearer 380-400.

In the month to 31 August 2021, valuation gains* added +319.7p (+9.0%), investment income* added +2.1p (+0.1%), foreign exchange movements* were +31.5p (+0.9%), share buybacks added +0.1p (+0.0%) and expenses and taxes**** were -6.2p (-0.2%).
Massive jump this month.
You can see why Jeffries moved to a buy on PIN yesterday.

What are your thoughts on the forward cost for Digital Decisions -

'This will be payable in 2023 and the amount due will be calculated as six times the average profit generated in the two years ended 31 December 2022 from digital media products developed by the Digital Innovation Centre, less the initial consideration of £700,000 paid in January 2020. The current estimate of the amount payable is £10.2 million..'

It is the first time I have seen numbers put to the agreement.
So this could be £5M and a 10% dilution (they have an option for it being paid in part by shares)?
Was this accounted for in the Edison report, I cannot see it specifically mentioned?

It has not appeared here but they are paying a final 7.5p Divi 'representing substantially all of the estimated revenue reserves of the Company at the relevant date'
Ex-Dividend Date 30 September 2021
Record Date 1 October 2021
Payment Date 8 October 2021
They have also published further details of the proposed discontinuation.

Seems to be on track and looks to be slightly ahead of Edison's estimates for revenue and PBT which is reassuring.

New global clients and 'the Board expects full year underlying operating profit to be slightly above previous expectations' holds promise for the second half.

If you want to follow the variants in the UK then I have found this useful-
https://www.gov.uk/government/publications/covid-19-variants-genomically-confirmed-case-numbers/variants-distribution-of-case-data-17-september-2021

Daughters school has run out, so I can believe this.

From Bloomberg-
U.S. health authorities plan to spend $2.1 billion to improve infection prevention and control across American health care, by far the largest single such outlay in the country’s history.
Amid crisis conditions created by Covid outbreaks, U.S. hospitals saw higher rates of antibiotic-resistant bacteria and infections linked to medical equipment like catheters or ventilators.
Some $880 million will go to health-care providers, academic institutions and nonprofits to develop new infection prevention measures, the agency said.
Going forward this could work out very well for Tristel.

The main issue is lack of drivers both in the US and to a lesser extent in the UK. There is even talk of using the Nation Guard in some regions. It is a fairly narrow margin business and if driver wage inflation is too high it quickly eats into the profits. They have negotiated a circa 3.7% increase in their contract values but I can see this easily being swallowed up in retention bonuses. In addition they will be liable to fines if they cannot run the service.
Even with the unemployed covid assistance being wound down vacancies for drivers advertised by Nelic have increased in past week the US.

Having their backing has done wonders for the sp since the w/e!

RTO's big push last year was disinfection services, with people returning to offices they are now focusing on air filtration. I think that once again the management are showing they are on the ball with their strategies. There was an article in the NY Times on this which showed how effective these can be-
'A study in a Melbourne hospital recently showed that adding two portable air cleaners to a patient’s room eliminated 99 percent of aerosols in minutes, reportedly raising the protection level equal to about 30 air changes per hour'
They are a visible and easy thing for a business to do - it will be interesting to say what they have to say about this new strand to the business at their capital markets day.

Not sure I agree with your view on that Babba.

'Gearing levels have increased to 3.8% (30 June 2020: £nil) and remain below our optimal operating range of between 10% and 20% as we cautiously manage our risk levels in a recovering market.'

Finally, our balance sheet remains rock solid and net debt at £13.0m is low so we have capacity to fund our strategic growth ambitions.

'The Company meets its day-to-day working capital requirements through a secured loan facility, which includes an overdraft facility. In January 2020, the Group concluded negotiations with three banking partners to put in place a £75m facility to replace the £72m facility we had in place at 31 December 2019, along with an accordion facility of £30m, which can be called upon at the Group's request.'

Ian Bull non executive director buys 4K shares @ 1422
Quite a bullish purchase after the recent rise.

Before todays results-
'The 7 analysts offering 12 month price targets for Dunelm Group plc have a median target of 1,550.00, with a high estimate of 1,850.00 and a low estimate of 1,150.00'

Net cash £128M, pre covid they were 30M debt- ordinary divi 35 p + 65p special divi.
What I also like is - ' the Board expects that FY22 PBT will be modestly ahead of the top of the range of analysts' expectations.'

Always nice to see and it seems to have helped the sentiment.
The coup in neighbouring Guinea does not appear to be of concern to buyers, RSG only have a small exploration presence there and the leaders of the coup have said they want the mining companies to keep running.
RSG is heavily shorted on the asx, so if they start to think that the tide is turning and close then this could tick up quite quickly.

Given the recent rise in share price, it is good to see the CFO only selling those performance awarded that he needed to, to cover tax.

It also seems that everyone seems is holding on to these quite tightly so it does not take much buying for the price to move up.

Two very good rns's today.
A carryover agreement worth 5M with OEM5, but also big change in the manufacturing strategy which will reduce capex by 10M and increase near term capacity. All backed by the bullish statement that they may need the extra capacity sooner than they had expected.

That is where the tie in with Adeptrix/Bruker will come into play. You use multiplexed affimers to pull down a suit of biomarkers and then MS to detect/confirm the ID's.